Article
Directed evolution of an LBP/CD14 inhibitory peptide and its anti-endotoxin activity.
PloS one - 1 Jan 2014
Fang Li, Xu Zhi, Wang Guan-song, Ji Fu-yun, Mei Chun-xia, Liu Juan, Wu Guo-ming
Abstract excerpt
BACKGROUND: LPS-binding protein (LBP) and its ligand CD14 are located upstream of the signaling pathway for LPS-induced inflammation. Blocking LBP and CD14 binding might prevent LPS-induced inflammation. In previous studies, we obtained a peptide analog (MP12) for the LBP/CD14 binding site and showed that this peptide analog had anti-endotoxin activity. In this study, we used in vitro directed evolution for this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
